Vontobel Holding
RLAY icon

Vontobel Holding’s Relay Therapeutics RLAY Stock Holding History

Vontobel Holding’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,432
Closed -$94.1K – 1124
2024
Q2 		$94.1K Buy
+14,432
New +$98.6K ﹤0.01% 1024
2022
Q2 		– Sell
-7,413
Closed -$222K – 1106
2022
Q1 		$222K Buy
7,413
+833
+13% +$20.2K ﹤0.01% 977
2021
Q4 		$202K Buy
+6,580
New +$208K ﹤0.01% 1003

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Vontobel Holding's RLAY Position: Q3 2024 in Review

Vontobel Holding sold out of Relay Therapeutics (RLAY) in Q3 2024, closing a stake of 14,432 shares — an estimated $94.1K sold.

Vontobel Holding first reported a position in RLAY in Q4 2021 and held it in 3 quarters. The position peaked at $222K in Q1 2022. 195 funds tracked by Wall St. Rank hold RLAY as of Q3 2024.

  • Vontobel Holding reported no remaining Relay Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Vontobel Holding sold 14,432 Relay Therapeutics shares in Q3 2024, an estimated $94.1K.
  • Vontobel Holding first reported a position in Relay Therapeutics in Q4 2021 and held it in 3 quarters.
  • Vontobel Holding's Relay Therapeutics position peaked at $222K in Q1 2022.
  • 195 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2024.

Based on Vontobel Holding's 13F filing for Q3 2024, filed 16 Oct 2024.